Clinical Trial Update: A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating PF-00915275 in adults with type 2 diabetes mellitus for 4 weeks was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-00915275 (PF-00915275)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: TERMINATED